FoxBioNet: ECV (Extracellular Vesicle) 004

NCT04603326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2023-10-16

No results posted yet for this study

Summary

The goal of this study is to identify reliable markers of LRRK2 activity in human CSF.

Conditions

  • Parkinson Disease

Interventions

PROCEDURE

Lumbar Puncture

Lumbar Puncture for collection of Cerebrospinal Fluids

Sponsors & Collaborators

  • Indiana University

    collaborator OTHER
  • University of Rochester

    collaborator OTHER
  • University Health Network, Toronto

    collaborator OTHER
  • Michael J. Fox Foundation for Parkinson's Research

    lead OTHER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04603326 on ClinicalTrials.gov